Volume 04| April 09, 2018
RxReins is a dedicated Managing General Underwriter (MGU) specializing in prescription stop loss insurance group benefit plans. We work closely with Brokers, TPA's and PBM's providing the best available products from multiple A-rated carriers in all fifty states . RxReins is a member of the ELMC Risk Solutions family of companies.
MONTHLY NEWS AND UPDATES!
REPORT SHOWS SKYROCKETING COST FOR 20 BRAND-NAME DRUGS

"Prices for each of the 20 most-prescribed brand-name drugs for seniors have increased dramatically every year for the past five years, according to a new report released by Sen.Claire McCaskill (D-Mo.) The cost of the drugs, which include brands like Advair, Crestor, Lyrica and Nexium, all increased an average of 12 percent every year for five years nearly 10-times higher than the rate of inflation, the report found."


"The administration will unveil a slate of proposals soon to address high prescription drug costs in the U.S. Health and Human Services Secretary Alex Azar said the administration would roll out the proposals in about a month. "We're going to be rolling out ... in about a month, a whole slate of other proposals around how we decrease the price of drugs, and how we bring discounts that right now the middle men are getting — how those will go to our patients, to individuals." 

LAUNCHING HIV COMBINATION THERAPIES AT SIGNIFICANTLY DISCOUNTED PRICE

"As the costs of HIV treatment continue to increase, drugmaker Mylan has announced it will launch two new combination HIV treatments at a significantly discounted price. The new combination treatments, Symfi Lo (efavirenz/lamivudine with tenofovir disoproxil fumarate; Mylan) and Cimduo (lamivudine with tenofovir disoproxil fumarate; Mylan) were approved by the FDA in February."

CHECK OUT OUR LATEST VIDEO

3 Ways to help Manage Specialty Drug Cost!
1) Clinical management : Implement 3 rd party clinical management who specializes in clinical review and prior authorization.
2) Review your formulary: Is your formulary clinically driven or rebate driven? A clinically driven Formulary will benefit you over the long run. A rebate driven formulary you will benefit you over the short term.
3) 30 day fill: Limit specialty drugs to 30 day fills and wait 6 months to a year before covering new FDA approvals.
To learn more sign up for our webinar Click to Register or visit our website. RxReins.com
WE WANT YOUR FEEDBACK

In order to continuously create innovative Rx solutions, please answer our 1 question survey. It will only take a few seconds to complete!
HAVE YOU EVER HEARD OF PRESCRIPTION DRUG STOP LOSS INSURANCE?
Yes
No
RxReins, LLC | 888.797.3467 | Stoploss@Rxreins.coml | www.rxreins.com